ibandronic acid has been researched along with Embolism, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergström, B; Body, JJ; Diel, I; Pecherstorfer, M; Rivkin, S | 1 |
1 trial(s) available for ibandronic acid and Embolism, Pulmonary
Article | Year |
---|---|
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Creatinine; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Leg; Middle Aged; Neoplasm Metastasis; Pulmonary Embolism; Survival Rate; Thrombosis; Time Factors; Treatment Outcome | 2006 |